Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Samsung buys Xealth to integrate consumer wearables and clinical data
Xealth’s data sharing platform will be used to make use of health information gathered from everyday devices like the Samsung Galaxy Smartwatch, the companies said.
CVS hit with $949M judgment over fraudulent Omnicare prescriptions
The pharmacy chain said it plans to appeal the ruling. The complaint was brought by a former employee turned whistleblower who alleged that Omnicare had billed the government for millions of unnecessary prescriptions.
Report: DOJ questioning doctors linked to possible Medicare fraud at UnitedHealth
According to the Wall Street Journal, the OIG and FBI are also involved in the DOJ's criminal probe into alleged incidents of upcoding by the Medicare Advantage insurer. UnitedHealth denied any wrongdoing.
Private equity firm buys health data analytics company Arcadia
With the buyout, global private equity investor Nordic Capital makes a big bet on healthcare AI. Arcadia said the influx of cash will be used to improve its technology and find new sources for data it can use for quality care initiatives.
Healthcare AI today: Mayo book, fraud busting, ‘shapeless monsters,’ more
Some AI researchers have taken to calling certain LLMs ‘Shoggoths.’ Be afraid. Be very afraid.

Amazon expands telehealth presence, offers primary care for $9 a month

Televisits will cost $9 a month or $99 per year and are facilitated by One Medical.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

ChatGPT neurology interview with neurologist

Experienced neurologist interviews generative AI, comes away impressed but not intimidated

ChatGPT can be a little sneaky. Recently asked if it’s ever messed up when helping physicians make clinical decisions, it only came clean with examples of stumbles after being pressed on the matter.

private equity corporatization business consolidation

Private equity-backed pharmaceutical company acquires stroke drug from Bayer

The drug, nimodipine, is a second-generation calcium channel blocker designed to prevent and treat cerebral vasospasm following an aneurysmal subarachnoid hemorrhage.